N
NNVC
Nanoviricides
0.9827
-0.0773-7.29%After Hours: 1.050 +0.067 +6.85%19:50 04/10 EDT
OPEN/PREV CLOSE1.040/1.060
TODAY RANGE0.9827-1.086
VOL128.00K
MARKET CAP21.22M
52 WEEK RANGE0.8500-2.230
AVG VOL (3M)255.66K
% TURNOVER0.59%
TURNOVER--
P/E (TTM)-2.0295
% RANGE9.57%
EPS(TTM)-0.4842
P/E(FORWARD)-2.7297
P/B1.917
BVPS0.5127
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP20.63M
SHARES OUTSTANDING21.59M
NEXT EARNINGS11/12-11/17
FREE FLOAT20.99M
LOT SIZE1
EX-DATE09/24/2019
News
Press Releases
Financial Reports
Profile
TipRanks·04/01 12:48
NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox
TipRanks·03/11 12:46
NanoViricides completes manufacture of NV-387 oral gummies
Benzinga·03/05 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga·02/17 22:02
Nanoviricides Q2 EPS $(0.11) Beats $(0.14) Estimate
TipRanks·02/12 13:50
NanoViricides files application for orphan drug designation for NV-387
TipRanks·01/13 14:02
NanoViricides comments on need for broad-spectrum antivirals
NASDAQ·01/12 03:55
After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers
TipRanks·12/16/2025 12:05
NanoViricides initiated with a Buy at Alliance Global
TipRanks·12/01/2025 13:45
NanoViricides signs Master Services Agreement with Only Orphans Cote
TipRanks·11/26/2025 22:04
NanoViricides Holds 2025 Annual Stockholders Meeting